Results 231 to 240 of about 223,172 (310)

Tumor control and survival after postoperative radiotherapy for high-risk oral cavity cancer: A retrospective cohort study. [PDF]

Clin Transl Radiat Oncol
Bolleurs PB, Jonker BP, Elbers JB, Verduijn GM, Gül A, Sewnaik A, Heemsbergen WD.   +6 more
europepmc   +1 more source

The Human Respiratory Virome in Health and Disease: Interactions, Dysbiosis, and Methodological Challenges

Advanced Genetics, EarlyView.
This article examines how the respiratory virome contributes to health and disease, highlighting its interactions with the host and bacteriome. Key disease associations and present knowledge gaps are outlined. The review discusses challenges in sample collection and preprocessing, and presents future research directions for understanding virome ...
Xiaoxuan Yao, Xiaohui Zou, Bin Cao
wiley   +1 more source

Increasing incidence, prevalence, and mortality of lip and oral cavity cancer in adults aged 70 and older globally: findings from GBD 2021. [PDF]

World J Surg Oncol
Chen S, Yang X, Huang L, Xie Y, Li Y, Lin Y.   +5 more
europepmc   +1 more source

Three Cases of Lung Cancer with Metastatic Involvement of Oral Cavity.

, 1997
Hiroyuki Tanaka, Hideo Kobayashi, Souichiro Kano, Naokazu Nagata, Shinsuke Aida, Keigo Takagi   +5 more
openalex   +2 more sources

Conceptual Study of Anukta Vyadhi – Oral Cavity Cancer with special reference to Mukhagata Roga

, 2020
Sushrut Sardeshmukh
openalex   +1 more source

Late Toxicity and Long‐Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi‐National Study

Head &Neck, EarlyView.
ABSTRACT Background Because salivary gland cancers (SGC) are rare and include different tumor subtypes, data on their long‐term quality of life and late toxicities are sparse. Methods Multi‐national study including SGC survivors more than 5 years after diagnosis.
Susanne Singer, Cecilie Delphin Amdal, Kristin Bjordal, Bente Brokstad Herlofson, Guro Lindviksmoen Astrup, Andreas Boehm, Ulrike Wöhner, Eva Hammerlid, Ricardo Ribeiro Gama, Alexandre Arthur Jacinto, Femke Jansen, Irma M. Verdonck‐de Leeuw, Tatiana Dragan, Fréderic Duprez, Naomi Kiyota, Monica Pinto, Maximilian Krüger, Orlando Guntinas‐Lichius, Johanna Inhestern, Francesco Tramacere, Pierluigi Bonomo, Giuseppe Fanetti, Sandra Nuyts, Michaela Plath, Noa Stempler, Kristine Løken Westgaard, Katherine J. Taylor   +26 more
wiley   +1 more source

Application of a Saliva‐Based Liquid Biopsy for the Detection of HPV in Patients With Oral Cavity Squamous Cell Carcinoma (OCSCC)

Head &Neck, EarlyView.
ABSTRACT Background Human papilloma virus (HPV) is a DNA virus capable of infecting mucous membranes. In most cases, the infection is cleared by the immune system, but a prolonged exposure to HPV can progress to cancer. 40%–60% of head and neck squamous cell carcinomas (HNSCC) are linked to HPV, which is considered a risk factor especially among young ...
Michela Bulfoni, Alessandro Tel, Beatrice Krpan, Barbara Marcon, Maria De Martino, Giorgia Vesca, Cinzia Lombardo, Stefania Marzinotto, Emanuele Nencioni, Salvatore Sembronio, Corrado Pipan, Massimo Robiony, Francesco Curcio   +12 more
wiley   +1 more source

Oral Cavity Cancer Secondary to Dental Trauma: A Scoping Review. [PDF]

Biomedicines
Chiesa-Estomba CM, Mayo-Yanez M, Vaira LA, Maniaci A, Feng AL, Landa-Garmendia M, Cardin-Pereda A, Lechien JR.   +7 more
europepmc   +1 more source

Screening and prophylaxis of periodontitis in the prevention of oral cavity cancer and its complications

, 2017
Iulia Cristina Micu, Alexandra Roman, Andrada Șoancă, Daniela Condor, Andreea Cândea   +4 more
openalex   +1 more source

Safety and Efficacy Findings From a Phase Ib/II Study of ASP‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background ASP‐1929 photoimmunotherapy—cetuximab conjugated to IRDye 700DX and red light (690 nm) for localized drug activation—results in rapid, selective cell killing. Methods This phase Ib/II open‐label study evaluated ASP‐1929 photoimmunotherapy plus pembrolizumab in patients with recurrent/metastatic HNSCC (≥ 1 accessible lesion, PD‐L1 ...
David M. Cognetti, Joseph M. Curry, Jennifer Johnson, Michael Kwon, Shirley Y. Su, Francisco Civantos, Coral Olazagasti, Joseph Valentino, Susanne M. Arnold, R. Bryan Bell, Michael K. Gibson, Kyle Mannion, Kathryn M. Van Abel, Katharine A. Price, Haiying Dong, Amy H. Thorne, Toshiaki Suzuki, Ann M. Gillenwater   +17 more
wiley   +1 more source